Stockchase Opinions

Peter Hodson Forbes Medi-Tech Inc FMTI-Q DON'T BUY Apr 08, 2004

Their plan was to have good results on their cholesterol drug and then raise $50 million. Results weren't that good and the stock dropped drastically.
$4.260

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY
The recent huge run is scary. Would like to see them raise some money.
BUY
Good management. Have some good projects and is a very interesting company.
HOLD
Biotechs are extremely market sensitive. Have to own a basket of them as they can be volatile. Formed a base in the 02/03's and had a rally in 04. Formed a higher low now so could be some more upside.
COMMENT
Had quite a base being formed over the last year or so. If you are a speculator, use a low from the past few weeks as a stop/loss. If you are a long-term investor, you can have your stop at a lower level.